HIT vs. NBIS

Last updated Jun 4, 2026

HIT (Health In Tech, Inc) and NBIS (Nebius Group N.V.) are both stocks. HIT operates in Software - Application (Technology), while NBIS operates in Internet Content & Information (Communication Services). Over the past year, HIT returned 51.97% vs 575.29% for NBIS. At a 0.15 correlation, their price movements are largely independent.

Performance

HIT vs. NBIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health In Tech, Inc (HIT) and Nebius Group N.V. (NBIS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HIT achieves a -39.31% return, which is significantly lower than NBIS's 200.67% return.

HIT

• 1D: -9.81%
• 1M: -36.51%
• YTD: -39.31%
• 6M: -25.19%
• 1Y: 51.97%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NBIS

• 1D: -3.42%
• 1M: 42.66%
• YTD: 200.67%
• 6M: 154.43%
• 1Y: 575.29%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HIT vs. NBIS - Yearly Performance Comparison

	2026 (YTD)	2025	2024
HIT Health In Tech, Inc	-39.31%	-70.31%	5.00%
NBIS Nebius Group N.V.	200.67%	202.18%	-3.28%

Correlation

The correlation between HIT and NBIS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (All Time) Calculated using the full available price history since Dec 24, 2024	0.15

Fundamentals

Market Cap HIT : $55.35M NBIS : $77.76B
EPS HIT : -$0.01 NBIS : $3.17
PS Ratio HIT : 1.63 NBIS : 75.53
PB Ratio HIT : 2.56 NBIS : 10.74
Total Revenue (TTM) HIT : $34.08M NBIS : $877.90M
Gross Profit (TTM) HIT : $20.09M NBIS : $420.60M
EBITDA (TTM) HIT : -$403.81K NBIS : -$52.78M

Return for Risk

HIT vs. NBIS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIT

HIT Risk / Return Rank: 59
HIT Sharpe Ratio Rank: 57
HIT Sortino Ratio Rank: 66
HIT Omega Ratio Rank: 63
HIT Calmar Ratio Rank: 56
HIT Martin Ratio Rank: 53

NBIS

NBIS Risk / Return Rank: 97
NBIS Sharpe Ratio Rank: 99
NBIS Sortino Ratio Rank: 96
NBIS Omega Ratio Rank: 93
NBIS Calmar Ratio Rank: 98
NBIS Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIT vs. NBIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Health In Tech, Inc (HIT) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HIT	NBIS	Difference
Sharpe ratio Return per unit of total volatility	0.45	5.52	-5.08
Sortino ratio Return per unit of downside risk	1.49	4.59	-3.10
Omega ratio Gain probability vs. loss probability	1.18	1.51	-0.33
Calmar ratio Return relative to maximum drawdown	0.68	12.77	-12.09
Martin ratio Return relative to average drawdown	1.09	29.34	-28.26
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HIT vs. NBIS - Sharpe Ratio Comparison

The current HIT Sharpe Ratio is 0.45, which is lower than the NBIS Sharpe Ratio of 5.52. The chart below compares the historical Sharpe Ratios of HIT and NBIS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HIT	NBIS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.45	5.52	-5.08
Sharpe Ratio (All Time) Calculated using the full available price history	-0.52	3.62	-4.14

Drawdowns

HIT vs. NBIS - Drawdown Comparison

The maximum HIT drawdown since its inception was -92.56%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for HIT and NBIS.

Drawdown Indicators

	HIT	NBIS	Difference
Max Drawdown Largest peak-to-trough decline	-92.56%	-58.27%	-34.29%
Max Drawdown (1Y) Largest decline over 1 year	-77.02%	-45.47%	-31.55%
Current Drawdown Current decline from peak	-87.06%	-4.85%	-82.21%
Average Drawdown Average peak-to-trough decline	-68.10%	-19.07%	-49.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	47.89%	19.74%	+28.15%

Volatility

HIT vs. NBIS - Volatility Comparison

Health In Tech, Inc (HIT) and Nebius Group N.V. (NBIS) have volatilities of 32.60% and 31.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HIT	NBIS	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.60%	31.82%	+0.78%
Volatility (6M) Calculated over the trailing 6-month period	74.05%	70.20%	+3.85%
Volatility (1Y) Calculated over the trailing 1-year period	117.16%	105.12%	+12.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	133.64%	110.56%	+23.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	133.64%	110.56%	+23.08%

Dividends

HIT vs. NBIS - Dividend Comparison

Neither HIT nor NBIS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both HIT and NBIS in my portfolio?

HIT and NBIS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HIT or NBIS?

HIT has higher volatility (32.60%) compared to NBIS (31.82%). In terms of maximum drawdown, HIT dropped -92.56% vs NBIS's -58.27%.

Which has better risk-adjusted returns?

NBIS currently has the higher Sharpe Ratio (5.52 vs 0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.